Self-financed Drugs Available for Purchase by Patients at HA Pharmacies
As a publicly-funded healthcare provider, the Hospital Authority (HA) does not supply drugs as a retailer. Patients should in general purchase self-financed drugs from community pharmacies. However, three categories of self-financed drugs are available for purchase by patients at HA pharmacies, including (1) drugs covered by the safety net, (2) very specialized drugs not readily available at community pharmacies and (3) drugs for meeting operational needs (e.g. injections), as follows:
As of 11 July 2020
|
Drugs With Safety Net 安全網藥物
|
|
1.
ABATACEPT
|
|
2.
ABIRATERONE
|
|
3.
ADALIMUMAB
|
|
4.
AFATINIB
|
|
5.
ALECTINIB
|
|
6.
ALEMTUZUMAB (LEMTRADA)
|
|
7.
AXITINIB
|
|
8.
AZACITIDINE
|
|
9.
BARICITINIB
|
|
10.
BENDAMUSTINE
|
|
11.
BEVACIZUMAB
|
|
12.
BORTEZOMIB
|
|
13.
BRENTUXIMAB VEDOTIN
|
|
14.
BRIGATINIB
|
|
15.
CANAKINUMAB
|
|
16.
CARFILZOMIB
|
|
17.
CERITINIB
|
|
18.
CERTOLIZUMAB
|
|
19.
CETUXIMAB
|
|
20.
CRIZOTINIB
|
|
21.
DABRAFENIB
|
|
22.
DASATINIB
|
|
23.
DOXORUBICIN (LIPOSOMAL)
|
|
24.
DURVALUMAB
|
|
25.
ECULIZUMAB
|
|
26.
ELTROMBOPAG
|
|
27.
ENZALUTAMIDE
|
|
28.
ETANERCEPT
|
|
29.
EVEROLIMUS (AFINITOR) [TABLET / DISPERSIBLE TABLET]
|
|
30.
GEFITINIB
|
|
31.
GOLIMUMAB
|
|
32.
GUSELKUMAB
|
|
33.
IBRUTINIB
|
|
34.
IMATINIB (GLIVEC) MESYLATE
|
|
35.
INFLIXIMAB (REMICADE / REMSIMA)
|
|
36.
INTERFERON GAMMA-1B
|
|
37.
IXAZOMIB
|
|
38.
LAPATINIB DITOSYLATE
|
|
39.
LENALIDOMIDE
|
|
40.
LENVATINIB
|
|
41.
MEPOLIZUMAB (NUCALA)
|
|
42.
MIDOSTAURIN
|
|
43.
NATALIZUMAB
|
|
44.
NILOTINIB HCl
|
|
45.
NINTEDANIB (OFEV) ESILATE
|
|
46.
NIVOLUMAB
|
|
47.
NUSINERSEN
|
|
48.
OBINUTUZUMAB
|
|
49.
OMALIZUMAB (XOLAIR)
|
|
50.
OSIMERTINIB
|
|
51.
PALBOCICLIB
|
|
52.
PANITUMUMAB
|
|
53.
PAZOPANIB
|
|
54.
PEMBROLIZUMAB
|
|
55.
PERTUZUMAB
|
|
56.
PLERIXAFOR
|
|
57.
RIBOCICLIB
|
|
58.
RITUXIMAB
|
|
59.
RUXOLITINIB
|
|
60.
SARILUMAB
|
|
61.
SECUKINUMAB
|
|
62.
SORAFENIB
|
|
63.
SUNITINIB
|
|
64.
TAFAMIDIS
|
|
65.
TEMOZOLOMIDE
|
|
66.
TOCILIZUMAB
|
|
67.
TOFACITINIB
|
|
68.
TOLVAPTAN (JINARC)
|
|
69.
TRAMETINIB
|
|
70.
TRASTUZUMAB (HERCEPTIN)
|
|
71.
TRASTUZUMAB EMTANSINE (KADCYLA)
|
|
72.
USTEKINUMAB
|
|
73.
VEDOLIZUMAB
|
|
74. VEMURAFENIB
|
|
Antipsychotic Drugs 抗精神病藥
|
|
1. ARIPIPRAZOLE
|
|
2. CLOZAPINE
|
|
3. PALIPERIDONE
|
|
4. RISPERIDONE
|
|
Antidepressant Drugs 抗抑鬱藥
|
|
1.
AGOMELATINE
|
|
2.
BUPROPION
|
|
3.
DESVENLAFAXINE
|
|
4.
DULOXETINE
|
|
5.
ESCITALOPRAM
|
|
6.
FLUVOXAMINE
|
|
7.
MILNACIPRAN
|
|
8.
PAROXETINE
|
|
9.
VENLAFAXINE
|
|
10. VORTIOXETINE
|
|
Drugs for Dementia 腦退化症藥物
|
|
1. DONEPEZIL
|
|
2. GALANTAMINE
|
|
3. RIVASTIGMINE
|
|
Oncology Drugs 腫瘤科藥物
|
|
1.
ABEMACICLIB
|
|
2.
ANAGRELIDE (AGRYLIN / THROMBOREDUCTIN)
|
|
3.
ANASTROZOLE
|
|
4.
ATEZOLIZUMAB (TECENTRIQ)
|
|
5.
BICALUTAMIDE
|
|
6.
BLEOMYCIN HCl
|
|
7.
BUSERELIN
|
|
8.
BUSULPHAN
|
|
9.
CABOZANTINIB (CABOMETYX) (S)-MALATE
|
|
10.
CLADRIBINE
|
|
11.
CLOFARABINE
|
|
12.
CYPROTERONE
|
|
13.
DEGARELIX
|
|
14.
DOCETAXEL
|
|
15.
ERIBULIN
|
|
16.
ERLOTINIB
|
|
17.
ESTRAMUSTINE
|
|
18.
EXEMESTANE
|
|
19.
FLUDARABINE
|
|
20.
FLUTAMIDE
|
|
21.
GOSERELIN
|
|
22.
IFOSFAMIDE
|
|
23.
IMATINIB (IMAKREBIN / HEMATOR) MESYLATE
|
|
24.
INOTUZUMAB OZOGAMICIN
|
|
25.
LANREOTIDE
|
|
26.
LEUPRORELIN
|
|
27.
LEUPRORELIN (ELIGARD)
|
|
28.
MITOXANTRONE
|
|
29.
OCTREOTIDE
|
|
30.
PEMETREXED
|
|
31.
POMALIDOMIDE
|
|
32.
PONATINIB
|
|
33.
REGORAFENIB
|
|
34.
TOPOTECAN
|
|
35.
TRIPTORELIN ACETATE / EMBONATE / PAMOATE
|
|
36.
TS-1
|
|
37. VINORELBINE
|
|
Immunosuppressants 免疫抑制劑
|
|
1. ANTITHYMOCYTE IMMUNOGLOBULIN
|
|
2. BASILIXIMAB
|
|
3. CYCLOSPORIN A
|
|
4. DIMETHYL FUMARATE
|
|
5. EVEROLIMUS
|
|
6. FINGOLIMOD
|
|
7. MYCOPHENOLATE
|
|
8. SIROLIMUS
|
|
9. TACROLIMUS
|
|
10. TERIFLUNOMIDE
|
|
Others 其他類別
|
|
1. AKYNZEO
|
|
2. APREPITANT
|
|
3. ENTECAVIR
|
|
4. TELBIVUDINE
|
|
5. TENOFOVIR DISOPROXIL FUMARATE
|
|
All Dangerous Drugs 所有危險藥物
|
|
All Injectable Drugs 所有注射藥物
|